1. Varadhan R, Segal JB, Boyd CM, Wu AW, Weiss CO. A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research. J Clin Epidemiol. 2013;66(8):818–25. doi:
10.1016/j.jclinepi.2013.02.009
.
2. West SL, Gartlehner G, Mansfield AJ, Poole C, Tant E, Lenfestey N, et al. Comparative Effectiveness Review Methods: Clinical Heterogeneity. Rockville: Agency for Healthcare Research and Quality; 2010. AHRQ Publication No. 10-EHC070-EF.
3. Gagnier JJ, Moher D, Boon H, Beyene J, Bombardier C. Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature. BMC Med Res Methodol. 2012;12:111.
4. Chou R, Dana T, Blazina I, Daeges M, Bougatsos C, Grusing S, et al. Statins for prevention of cardiovascular disease in adults: systematic review for the U.S. Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality; 2015. AHRQ Publication No. 14-05206-EF-2.
5. Guirguis-Blake JM, Evans CV, Senger CA, Rowland MG, O'Connor EA, Whitlock EP. Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality; 2015. AHRQ Publication No. 13-05195-EF-1.